Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 944.15
-7.25 (-0.76%)
Nov 13, 2025, 3:30 PM IST
Zydus Lifesciences Employees
Zydus Lifesciences had 27,917 employees as of March 31, 2025. The number of employees increased by 996 or 3.70% compared to the previous year.
Employees
27,917
Change (1Y)
996
Growth (1Y)
3.70%
Revenue / Employee
8.77M INR
Profits / Employee
1.76M INR
Market Cap
957.33B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | 24,412 | -588 | -2.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Biocon | 16,315 |
| Glenmark Pharmaceuticals | 15,800 |
Zydus Lifesciences News
- 2 days ago - Zydus Lifesciences secures first-ever approval from China’s NMPA for Venlafaxine ER Capsules - Business Upturn
- 6 days ago - Zydus Lifesciences Ltd (BOM:532321) Q2 2026 Earnings Call Highlights: Robust Revenue Growth ... - GuruFocus
- 6 days ago - Q2 2026 Zydus Lifesciences Ltd Earnings Call Transcript - GuruFocus
- 7 days ago - Zydus Lifesciences receives USFDA Orphan Drug Designation for Desidustat to treat beta-thalassemia - Business Upturn
- 8 days ago - Zydus Lifesciences receives ‘No Action Indicated’ classification from USFDA for Ahmedabad SEZ-II facility - Business Upturn
- 12 days ago - Zydus Lifesciences receives GST demand order worth Rs 74.23 crore; to challenge ruling - Business Upturn
- 13 days ago - Zydus and Lupin shares in focus today after Astellas raises Mirabegron guidance by 80% - Business Upturn
- 5 weeks ago - Zydus Lifesciences receives Health Canada approval for Liothyronine tablets 5 mcg and 25 mcg - Business Upturn